The Evolving COVID-19 Market: FDA Clears the Way for Asymptomatic Screening Products
...
COVID-19 Surge Lifts Overall Molecular Point of Care Testing Market to $900 Million
...
FDA to SARS-CoV-2 Test Developers: Evaluate Impact of Genetic Mutations on Test Performance
...
FDA Clears the Way for Serial Use At-Home and Point-of-Care Asymptomatic Screening Tests
...